Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine

Journal Belge de Radiologie

Volumn 82, Issue 4, 1999, Pages 153-154

  Colebunders, R ^a,b   Depraetere, K ^a,b   De Droogh, E ^a,b   Kamper, A ^b   Corthout, B ^b   Bottiau, E ^a,b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Kidney, failure

Indexed keywords

CAPTOPRIL; DIGOXIN; FOLINIC ACID; FUROSEMIDE; INDOMETACIN; PYRIMETHAMINE; SCOPOLAMINE BUTYL BROMIDE; SULFADIAZINE; TRIAMTERENE;

ADULT; ALKALINIZATION; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; KIDNEY COLIC; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TOXOPLASMOSIS; TREATMENT OUTCOME; URETER OBSTRUCTION; URETER STONE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALKALIES; ANTIPROTOZOAL AGENTS; CRYSTALLIZATION; FEMALE; FLUID THERAPY; HIV SEROPOSITIVITY; HUMANS; HYDRONEPHROSIS; KIDNEY CALCULI; MALE; MIDDLE AGED; SULFADIAZINE; TOXOPLASMOSIS, CEREBRAL; URETERAL DISEASES;

EID: 0032834558     PISSN: 00217646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Haverkos H. W.: Assessment of therapy for toxoplasma encephalitis. Am J Med, 1987, 82: 907-914.
2. Marques L.P., Silva, Madeira, Santos: Obstructive renal failure due to therapy with sulfadiazine in an AIDS patient. Nefron, 1992, 62: 361.
3. Oster S., Hutchison F., Mc Cabe R.: Resolution of acute renal failure in toxoplasmic encephalitis despite continuance of sulfadiazine. Rev Infect Dis, 1990, 12: 618-20.
4. Simon D.I., Brosius F.C., Rothstein D.M.: Sulfadiazine Crystalluria Revisited. The Treatment of Toxoplasma Encephalitis in Patients with Acquired Immunodeficiency Syndrome. Arch Intern Med, 1990, 150: 2379-2384.
5. Molina J.M., Belenfant X., Doco-Lecompte T., Idatte J.M., Modai J.: Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. AIDS, 1991, 5: 587-589.
6. Mir N., O'Farrell N., Creagh T.A., Knowles C.: Obstructive renal failure requiring surgical intervention in an AIDS patient being treated with sulphadiazine. Int J STD AIDS, 1997, 8: 61-62.
7. Di Fiori J.L., Rodrique D., Kaptein E.M., Ralls P.W.: Diagnostic sonography of HIV-associated nephropathy: new observations and clinical correlation. Am J Roentgenol, 1998, 171: 713-716.
8. Frehr D.: Clinical toxicity of sulfanamides. Am NY Acad Sci, 1957, 69: 417-447.
9. Flexner C.: HIV protease inhibitors. N Engl J Med, 1998, 338: 1281-1292.
10. Daudon M., Estépa L., Viard J.P., Joly D., Jungers P.: Urinary stones in HIV-positive patients treated with the protease inhibitor indinavir sulphate. Lancet, 1997, 349: 1294-1295.
11. Schwartz B.F., Schenkman N., Armenakas N.A., Stoller M.L.: Imaging characteristics of indinavir calculi. J Urol, 1999, 161: 1085-1087.
12. Blake S.P., McNicholas M.M.J., Raptopoulos V.: Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy. Am J Roentgenol, 1998, 171: 717-720.